BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol 2015; 7(16): 2009-2019 [PMID: 26261690 DOI: 10.4254/wjh.v7.i16.2009]
URL: https://www.wjgnet.com/1007-9327/full/v7/i16/2009.htm
Number Citing Articles
1
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
2
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
3
Shou-Wu Lee, Teng-Yu Lee, Yu-Chi Cheng, Chieh-Ling Yen, Sheng Shun Yang. The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolizationMedicine 2021; 100(26): e26414 doi: 10.1097/MD.0000000000026414
4
Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio Cea, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli. TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular CarcinomaJournal of Personalized Medicine 2021; 11(10): 1041 doi: 10.3390/jpm11101041
5
Amar Karalli, Johan Teiler, Mojgan Haji, Elin Seth, Torkel B. Brismar, Staffan Wahlin, Rimma Axelsson, Per Stål. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life settingScandinavian Journal of Gastroenterology 2019; 54(7): 905 doi: 10.1080/00365521.2019.1632925
6
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCCHepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
7
Juanfang Liu, Shanshan Xie, Xuhua Duan, Jianjian Chen, Xueliang Zhou, Yahua Li, Zhaonan Li, Xinwei Han. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinomaCancer Chemotherapy and Pharmacology 2020; 85(1): 69 doi: 10.1007/s00280-019-04004-z
8
Ze-Feng Zhang, Yu-Jun Luo, Quan Lu, Shi-Xue Dai, Wei-Hong Sha. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?World Journal of Clinical Cases 2018; 6(9): 259-273 doi: 10.12998/wjcc.v6.i9.259
9
Brian A. Scansen. Interventional RadiologyVeterinary Clinics of North America: Small Animal Practice 2016; 46(3): 535 doi: 10.1016/j.cvsm.2015.12.009
10
Brian I. Carr, Srikanth Nagalla, Ravit Geva. Hepatocellular Carcinoma2016; : 489 doi: 10.1007/978-3-319-34214-6_33
11
Cao-ye Wang, Jin-guo Xia, Zheng-qiang Yang, Wei-zhong Zhou, Wen-hua Chen, Chun-jian Qi, Jian-ping Gu, Qi Wang. Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61209-6
12
Yan Zhang, Mei-Wu Zhang, Xiao-Xiang Fan, Da-Feng Mao, Quan-Hua Ding, Lu-Hui Zhuang, Shu-Yi Lv. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2020; 12(8): 355-368 doi: 10.4240/wjgs.v12.i8.355
13
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, Massimo Iavarone, Angelo Sangiovanni, Filippo Pesapane, Enrico Maria Fumarola, Pietro Lampertico, Gianpaolo Carrafiello. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCCCancers 2021; 13(22): 5797 doi: 10.3390/cancers13225797
14
Shen Zhengjie, Gu Wenzhe, Cheng Haibo, Shen Weixing, Sun Dongdong, Zeng Yun, Tao Lihuiping, Wu Mianhua. Effect of Aidi injection plus transarterial chemoembolization on primary hepatic carcinoma: a systematic review and Meta-analysisJournal of Traditional Chinese Medicine 2017; 37(5): 567 doi: 10.1016/S0254-6272(17)30310-2
15
Antonio Facciorusso. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the artWorld Journal of Gastroenterology 2018; 24(2): 161-169 doi: 10.3748/wjg.v24.i2.161
16
Lunxu Li, Shilin Xia, Xueying Shi, Xu Chen, Dong Shang. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89747-7
17
M. Massani, T. Stecca, C. Ruffolo, N. Bassi. Should we routinely use DEBTACE for unresectable HCC? cTACE versus DEBTACE: a single-center survival analysisUpdates in Surgery 2017; 69(1): 67 doi: 10.1007/s13304-017-0414-3
18
Shao-Hua Lee, Chia-Ying Lin, Ya-Chun Hsu, Yi-Sheng Liu, Ming-Tsung Chuang, Ming-Ching Ou. Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma PatientsCancer Research and Treatment 2020; 52(1): 24 doi: 10.4143/crt.2019.018
19
Olga Kantor, Marshall S. Baker. Gastrointestinal MalignanciesCancer Treatment and Research 2016; : 165 doi: 10.1007/978-3-319-34244-3_8
20
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosisThe Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
21
Antonio Facciorusso, Marianna Di Maso, Nicola Muscatiello. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysisDigestive and Liver Disease 2016; 48(6): 571 doi: 10.1016/j.dld.2016.02.005
22
Natascha Roehlen, Richard F. Knoop, Katharina Laubner, Jochen Seufert, Henning Schwacha, Robert Thimme, Andreas Fischer. Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case ReportCase Reports in Gastroenterology 2018; 12(2): 352 doi: 10.1159/000490604
23
Ying Zhang, Dejian Hu, Shangcong Han, Guowen Yan, Chao Ma, Chen Wei, Miao Yu, Dongmei Li, Yong Sun. Preparation and evaluation of reduction-responsive nano-micelles for miriplatin deliveryExperimental Biology and Medicine 2016; 241(11): 1169 doi: 10.1177/1535370215625473
24
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinomaJournal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
25
Antonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Saurabh Chandan, Antonio Ambrosi, Irene Bargellini, Matteo Renzulli, Rodolfo Sacco. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysisDigestive and Liver Disease 2021;  doi: 10.1016/j.dld.2021.06.003
26
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello. Transarterial radioembolization <i>vs</i> chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysisWorld Journal of Hepatology 2016; 8(18): 770-778 doi: 10.4254/wjh.v8.i18.770
27
William T.N. Culp. Interventional OncologyVeterinary Clinics of North America: Small Animal Practice 2016; 46(3): 553 doi: 10.1016/j.cvsm.2015.12.010
28
Sung Won Chung, Min Kyung Park, Young Youn Cho, Youngsu Park, Cheol-Hyung Lee, Hyunwoo Oh, Heejoon Jang, Minseok Albert Kim, Sun Woong Kim, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Hyo-Cheol Kim, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon, Jeong-Hoon Lee. Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisJournal of Hepatocellular Carcinoma 2021; : 587 doi: 10.2147/JHC.S294440
29
Mengdie Zhao, Ping Xiang, Hao Jiang. TransArterial ChemoEmbolization (TACE) with platinum versus anthracyclines for hepatocellular carcinoma: A meta-analysisInternational Journal of Surgery 2018; 53: 151 doi: 10.1016/j.ijsu.2018.03.049
30
Julie K. Heimbach, Laura M. Kulik, Richard S. Finn, Claude B. Sirlin, Michael M. Abecassis, Lewis R. Roberts, Andrew X. Zhu, M. Hassan Murad, Jorge A. Marrero. AASLD guidelines for the treatment of hepatocellular carcinomaHepatology 2018; 67(1): 358 doi: 10.1002/hep.29086
31
Matthew P. Lungren, Alexander J. Towbin, Derek J. Roebuck, Eric J. Monroe, Anne E. Gill, Avnesh Thakor, Richard B. Towbin, Anne Marie Cahill, C. Matthew Hawkins. Role of interventional radiology in managing pediatric liver tumorsPediatric Radiology 2018; 48(4): 555 doi: 10.1007/s00247-018-4068-1
32
Masakazu Hirakawa, Torahiko Yamanouchi, Satoru Tsuruta, Akihiro Inoue, Hidenari Hirata, Keiji Matsumoto, Katsumi Sakamoto, Hironori Sakai, Koshi Mimori, Hiroshi Honda. Midterm Outcomes and Prognostic Factors of Patients Treated Using Microballoon-Occluded Transarterial Chemoembolization with Miriplatin: A Retrospective Study of 37 CasesInterventional Radiology 2018; 3(3): 97 doi: 10.22575/interventionalradiology.2018-0001
33
Hongwei Zhao, Fuquan Liu, Zhendong Yue, Lei Wang, Zhenhua Fan, Fuliang He. Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative deathJournal of International Medical Research 2017; 45(3): 1148 doi: 10.1177/0300060517704141
34
Katrin Fuchs, Rafael Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan. Drug-eluting embolic microspheres for local drug delivery – State of the artJournal of Controlled Release 2017; 262: 127 doi: 10.1016/j.jconrel.2017.07.016
35
Abhishek Bansal, Arvind Chaturvedi. Interventional Radiological Management of Hepatocellular CarcinomaIndian Journal of Medical and Paediatric Oncology 2020; 41(04): 484 doi: 10.4103/ijmpo.ijmpo_256_19
36
Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) ProgressionCancer Management and Research 2021; : 4013 doi: 10.2147/CMAR.S304591
37
Pierleone Lucatelli, Renato Argirò, Gianluca De Rubeis, Bianca Rocco, Stefano Ginanni Corradini, Mario Corona, Pier Giorgio Nardis, Luca Saba, Gianluca Mennini, Francesco Fiorentino, Alessandro Corsi, Carlo Catalano, Mario Bezzi. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current StandardsJournal of Vascular and Interventional Radiology 2019; 30(3): 305 doi: 10.1016/j.jvir.2018.10.026
38
Antonio Facciorusso, Francesco Bellanti, Rosanna Villani, Veronica Salvatore, Nicola Muscatiello, Fabio Piscaglia, Gianluigi Vendemiale, Gaetano Serviddio. Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta‐analysis of randomized trialsUnited European Gastroenterology Journal 2017; 5(4): 511 doi: 10.1177/2050640616673516
39
C. L. Chiang, Mark K. H. Chan, Cynthia S. Y. Yeung, Connie H. M. Ho, Francis A. S. Lee, Venus W. Y. Lee, Frank C. S. Wong, Oliver Blanck. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B–C hepatocellular carcinomaStrahlentherapie und Onkologie 2019; 195(3): 254 doi: 10.1007/s00066-018-1391-2
40
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2020; 12(6): 663-676 doi: 10.4251/wjgo.v12.i6.663
41
Yong Kang Lee, Kyu Sik Jung, Do Young Kim, Jin Young Choi, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Gyoung Min Kim, Man Deuk Kim, Sung Il Park, Jong Yun Won, Do Yun Lee. Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor sizeJournal of Gastroenterology and Hepatology 2017; 32(2): 487 doi: 10.1111/jgh.13501
42
Pierleone Lucatelli, Gianluca De Rubeis, Fabrizio Basilico, Luca Ginanni Corradini, Mario Corona, Mario Bezzi, Carlo Catalano. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACELa radiologia medica 2019; 124(12): 1212 doi: 10.1007/s11547-019-01076-y
43
Lin Zhou, Lin-Zhi Zhang, Jing-Yan Wang, Yong-Wu Li, Hai-Dong Hu, Xiao-Ming Peng, Yun Zhao, Xi-Ming Wang, Hui Xie, Chun-Zi Liu, Hua-Ming Wang. Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopeniaMolecular and Clinical Oncology 2017; 7(3): 435 doi: 10.3892/mco.2017.1345
44
Michele Barone, Alfredo Di Leo, Carlo Sabbà, Antonio Mazzocca. The perplexity of targeting genetic alterations in hepatocellular carcinomaMedical Oncology 2020; 37(8) doi: 10.1007/s12032-020-01392-8
45
Delia D’Avola, Alessandro Granito, Manuel de la Torre-Aláez, Fabio Piscaglia. The importance of liver functional reserve in the non-surgical treatment of Hepatocellular CarcinomaJournal of Hepatology 2021;  doi: 10.1016/j.jhep.2021.11.013
46
Maria Baimas-George, Michael Watson, Jesse Sulzer, Patrick Salibi, Keith J. Murphy, David Levi, John B. Martinie, Dionisios Vrochides, Erin H. Baker, Lee Ocuin, David A. Iannitti. Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablationSurgical Endoscopy 2021; 35(6): 3122 doi: 10.1007/s00464-020-07747-6
47
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistanceChemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
48
Zhe-Xuan Wang, Jing Li, En-Xin Wang, Dong-Dong Xia, Wei Bai, Qiu-He Wang, Jie Yuan, Xiao-Mei Li, Jing Niu, Zhan-Xin Yin, Jie-Lai Xia, Dai-Ming Fan, Guo-Hong Han. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolizationWorld Journal of Gastroenterology 2020; 26(15): 1805-1819 doi: 10.3748/wjg.v26.i15.1805
49
Soon Young Ko, Won Hyeok Choe. Potential prognostic factors for solitary hepatocellular carcinoma ≤ 5 cm after transarterial chemoembolizationThe Korean Journal of Internal Medicine 2019; 34(6): 1210 doi: 10.3904/kjim.2019.344
50
Antonio Facciorusso, Irene Bargellini, Marina Cela, Ivan Cincione, Rodolfo Sacco. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score AnalysisCancers 2020; 12(4): 897 doi: 10.3390/cancers12040897